STERIS Pre-Tax Profit Margin 2010-2022 | STE

Current and historical pre-tax profit margin for STERIS (STE) from 2010 to 2022. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. STERIS pre-tax profit margin for the three months ending September 30, 2022 was .
STERIS Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2022-09-30 $4.78B $0.06B 1.15%
2022-06-30 $4.77B $0.48B 10.01%
2022-03-31 $4.59B $0.31B 6.85%
2021-12-31 $4.25B $0.38B 8.92%
2021-09-30 $3.85B $0.34B 8.73%
2021-06-30 $3.41B $0.38B 11.15%
2021-03-31 $3.11B $0.52B 16.67%
2020-12-31 $3.06B $0.53B 17.34%
2020-09-30 $3.02B $0.53B 17.37%
2020-06-30 $3.00B $0.51B 16.92%
2020-03-31 $3.03B $0.50B 16.43%
2019-12-31 $2.98B $0.48B 16.23%
2019-09-30 $2.90B $0.41B 14.04%
2019-06-30 $2.84B $0.39B 13.56%
2019-03-31 $2.78B $0.37B 13.26%
2018-12-31 $2.73B $0.34B 12.34%
2018-09-30 $2.70B $0.37B 13.76%
2018-06-30 $2.65B $0.36B 13.69%
2018-03-31 $2.62B $0.35B 13.51%
2017-12-31 $2.59B $0.30B 11.61%
2017-09-30 $2.57B $0.22B 8.68%
2017-06-30 $2.58B $0.20B 7.55%
2017-03-31 $2.61B $0.18B 7.04%
2016-12-31 $2.62B $0.23B 8.58%
2016-09-30 $2.59B $0.24B 9.22%
2016-06-30 $2.44B $0.20B 8.00%
2016-03-31 $2.24B $0.17B 7.64%
2015-12-31 $2.05B $0.15B 7.17%
2015-09-30 $1.91B $0.18B 9.19%
2015-06-30 $1.88B $0.21B 11.13%
2015-03-31 $1.85B $0.21B 11.35%
2014-12-31 $1.81B $0.20B 11.08%
2014-09-30 $1.75B $0.20B 11.16%
2014-06-30 $1.67B $0.19B 11.51%
2014-03-31 $1.62B $0.19B 11.58%
2013-12-31 $1.59B $0.19B 12.11%
2013-09-30 $1.56B $0.20B 13.08%
2013-06-30 $1.53B $0.22B 14.16%
2013-03-31 $1.50B $0.23B 15.12%
2012-12-31 $1.46B $0.24B 16.34%
2012-09-30 $1.44B $0.23B 15.79%
2012-06-30 $1.43B $0.21B 14.95%
2012-03-31 $1.41B $0.21B 15.00%
2011-12-31 $1.40B $0.19B 13.91%
2011-09-30 $1.37B $0.18B 12.87%
2011-06-30 $1.34B $0.18B 13.69%
2011-03-31 $1.21B $0.07B 6.05%
2010-12-31 $1.16B $0.07B 5.77%
2010-09-30 $1.16B $0.09B 7.84%
2010-06-30 $1.16B $0.09B 7.39%
2010-03-31 $1.26B $0.19B 15.26%
2009-12-31 $1.27B $0.19B 14.88%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $18.026B $4.585B
STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $216.198B 22.61
Edwards Lifesciences (EW) United States $47.210B 32.49
Alcon (ALC) Switzerland $33.483B 28.83
Teleflex (TFX) United States $10.579B 17.16
Fresenius Medical Care AG KGaA (FMS) Germany $9.137B 9.17
Penumbra (PEN) United States $7.442B 1781.27
Globus Medical (GMED) United States $7.143B 36.31
Integer Holdings (ITGR) United States $2.386B 19.15
Glaukos (GKOS) United States $2.248B 0.00
Nevro (NVRO) United States $1.572B 0.00
Paragon 28 (FNA) United States $1.556B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.248B 17.77
Artivion (AORT) United States $0.525B 0.00